The distribution of isomorphic forms of prolactin in the serum of pregnant women was studied by gel filtration chromatography. Using this technique we were able to resolve three peaks, detected by radioimmunoassay: they were termed 'big-big', 'big' and 'little' prolactin in order of decreasing size, with approximate molecular weights > 100 000, 50 000 and 21 000 respectively. They displayed a comparable immunoreactivity to the antiserum employed in the radioimmunoassay, as determined in competition experiments. The relative amount of each hormone form in serum changed during the third trimester of pregnancy. At week 33 of pregnancy, 'little' prolactin accounted for 63\m=.\2\ m=+-\ 7\ m=. \ 7% of the total circulating hormone present in the serum of five normal pregnant women. During the progression of pregnancy, there was a gradual increase in the low molecular weight prolactin, so that, at the time of delivery, the larger forms of the hormone were present only in small amounts.
INTRODUCTION
As measured in gel filtration experiments, prolactin appears to be present in multiple forms of different size in maternal and fetal serum, as well as in cerebrospinal and amniotic fluid (Fang & Kim, 1975; Keiffer & Malarkey, 1978) . Two peaks of radioimmunoassayable activity have consistently been found: the elution volume of the prevalent forms coincides with the Chro¬ matographie position of an iodine-labelled monomeric prolactin tracer ('little' prolactin, mol . wt = 21 000), while the residual activity emerges in a smaller peak of apparent molecular weight of 50 000 ('big' prolactin) . Only in some patients is a third form present with an estimated molecular weight greater than 100000 ('bigbig' prolactin) .
Very little is known about these isomorphic forms of prolactin and it has been suggested that the larger forms may be less active biologically, since they display lower affinity for the prolactin receptor (Farkouh, Packer & Frantz, 1979) . In any case little information is available on the relative distribution of the larger prolactin forms in physiological conditions. The aim of the present investigation was to verify the composition of serum prolactin immunoreactive material during normal pregnancy. Our results demonstrate that large prolactin forms, 'big' and 'big-big' prolactin, are 
DISCUSSION
Our data confirm the existence of multiple forms of prolactin of different molecular weights in the serum of pregnant women and further document significant changes in the distribution of these forms during preg¬ nancy. In particular, a decrease in the large forms of the hormone and a corresponding increase in the con¬ centration of 'little' prolactin towards term was evi¬ dent (Fig. 1) . The molecular basis for this phenomenon is unclear at present but it is evident that (i) these molecular forms have some antigenic determinant (re¬ cognized by the antiserum employed) in common, as demonstrated by immunological cross-reactivity and that (ii) all these forms bind to receptors present at the target tissue level, even though with different affinity (Kelly, Ferland, Labrie & De Lean, 1976; Farkouh et al. 1979; Dubé, Kelly & Pelletier, 1980; Shiu & Friesen, 1980 (Shiu & Friesen, 1980 ), but an alter¬ native possible explanation for this finding would be the prevalence of high molecular weight forms of pro¬ lactin, with their low binding affinity to the prolactin receptor, but clearly this must be proven experiment¬ ally.
In conclusion, our data demonstrate a modification of levels of the isomorphic forms of prolactin during normal pregnancy, but the significance of this observa¬ tion cannot be appreciated until the exact physio¬ logical role of the multiple prolactin forms is clearly understood. One possibility to be explored would be to correlate known physiological or pathological changes in prolactin function with the serum patterns of isoprolactins.
